Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Reducing FOXA2 in skin cells lowers their ability to grow hair.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

NXC736 significantly reduced hair loss in mice with alopecia areata.

The enzyme 25 Hydroxyvitamin D 1 α-Hydroxylase is essential for healthy skin and recovery after skin damage.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

The GPRC6A-Duox1 axis helps control hair growth and loss by affecting hydrogen peroxide production.

Two mouse mutations cause similar hair loss despite different skin changes.

Congenital atrichia with papular lesions causes permanent hair loss and skin bumps due to a gene mutation.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Alopecia Areata Incognita causes sudden hair loss in young females but usually has a better outcome than other types.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

15-lipoxygenase helps keep skin healthy by reducing inflammation.

The KRTAP21-1 gene affects wool yield and can help improve wool production.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.